Wanessa M C Awata, Gustavo F Pimenta, Thales M H Dourado, Kathleen A Paulino, Marcela M Blascke de Mello, Lucas C Pinheiro, Michele M Castro, Carlos R Tirapelli
{"title":"AT1受体通过增加血管周围脂肪组织中iNOS的表达,在脓毒症诱导的血管截瘫中发挥作用。","authors":"Wanessa M C Awata, Gustavo F Pimenta, Thales M H Dourado, Kathleen A Paulino, Marcela M Blascke de Mello, Lucas C Pinheiro, Michele M Castro, Carlos R Tirapelli","doi":"10.1007/s00424-025-03113-4","DOIUrl":null,"url":null,"abstract":"<p><p>Sepsis enhances the anticontractile effect of perivascular adipose tissue (PVAT), which contributes to a reduced response to vasoconstrictor agents. In the early stages of sepsis, the renin-angiotensin-aldosterone system (RAAS) is activated, and this response can lead to poorer clinical outcomes. We hypothesized that AT<sub>1</sub> receptors (AT<sub>1</sub>R) contribute to vascular hyporesponsiveness during sepsis by increasing the expression of inducible nitric oxide synthase (iNOS) in the periaortic PVAT, resulting in elevated nitric oxide (NO) production. In our study, male Wistar Hannover rats underwent lethal sepsis via a cecal ligation and puncture (CLP) model. We evaluated the role of AT<sub>1</sub>R in sepsis-induced PVAT dysfunction by administering a single dose of losartan (a selective AT<sub>1</sub>R antagonist; 10 mg/kg, gavage) to the rats 1 h prior to the CLP surgery. We observed increased levels of circulating angiotensin II in septic rats. Functional analyses revealed that AT<sub>1</sub>R blockade prevented the enhanced anticontractile effect of PVAT and the resulting vascular hyporesponsiveness to phenylephrine during sepsis. Additionally, losartan inhibited sepsis-induced iNOS expression and the overproduction of NO in both the PVAT and the aorta. Experiments using 1400W, a selective iNOS inhibitor, indicated that iNOS plays a crucial role in the sepsis-induced increase in the anticontractile effect of PVAT. In summary, AT<sub>1</sub>R mediate iNOS expression in PVAT, leading to the overproduction of NO, which ultimately contributes to sepsis-induced vasoplegia. Furthermore, AT<sub>1</sub>R-mediated iNOS expression is an important mechanism related to vasoplegia in the vasculature. The present results implicate AT<sub>1</sub>R as active players in sepsis-induced PVAT and vascular dysfunction.</p>","PeriodicalId":19954,"journal":{"name":"Pflugers Archiv : European journal of physiology","volume":" ","pages":"1259-1271"},"PeriodicalIF":2.9000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"AT<sub>1</sub> receptors play a role in sepsis-induced vasoplegia by increasing iNOS expression in the perivascular adipose tissue.\",\"authors\":\"Wanessa M C Awata, Gustavo F Pimenta, Thales M H Dourado, Kathleen A Paulino, Marcela M Blascke de Mello, Lucas C Pinheiro, Michele M Castro, Carlos R Tirapelli\",\"doi\":\"10.1007/s00424-025-03113-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Sepsis enhances the anticontractile effect of perivascular adipose tissue (PVAT), which contributes to a reduced response to vasoconstrictor agents. In the early stages of sepsis, the renin-angiotensin-aldosterone system (RAAS) is activated, and this response can lead to poorer clinical outcomes. We hypothesized that AT<sub>1</sub> receptors (AT<sub>1</sub>R) contribute to vascular hyporesponsiveness during sepsis by increasing the expression of inducible nitric oxide synthase (iNOS) in the periaortic PVAT, resulting in elevated nitric oxide (NO) production. In our study, male Wistar Hannover rats underwent lethal sepsis via a cecal ligation and puncture (CLP) model. We evaluated the role of AT<sub>1</sub>R in sepsis-induced PVAT dysfunction by administering a single dose of losartan (a selective AT<sub>1</sub>R antagonist; 10 mg/kg, gavage) to the rats 1 h prior to the CLP surgery. We observed increased levels of circulating angiotensin II in septic rats. Functional analyses revealed that AT<sub>1</sub>R blockade prevented the enhanced anticontractile effect of PVAT and the resulting vascular hyporesponsiveness to phenylephrine during sepsis. Additionally, losartan inhibited sepsis-induced iNOS expression and the overproduction of NO in both the PVAT and the aorta. Experiments using 1400W, a selective iNOS inhibitor, indicated that iNOS plays a crucial role in the sepsis-induced increase in the anticontractile effect of PVAT. In summary, AT<sub>1</sub>R mediate iNOS expression in PVAT, leading to the overproduction of NO, which ultimately contributes to sepsis-induced vasoplegia. Furthermore, AT<sub>1</sub>R-mediated iNOS expression is an important mechanism related to vasoplegia in the vasculature. The present results implicate AT<sub>1</sub>R as active players in sepsis-induced PVAT and vascular dysfunction.</p>\",\"PeriodicalId\":19954,\"journal\":{\"name\":\"Pflugers Archiv : European journal of physiology\",\"volume\":\" \",\"pages\":\"1259-1271\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pflugers Archiv : European journal of physiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00424-025-03113-4\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"PHYSIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pflugers Archiv : European journal of physiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00424-025-03113-4","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PHYSIOLOGY","Score":null,"Total":0}
AT1 receptors play a role in sepsis-induced vasoplegia by increasing iNOS expression in the perivascular adipose tissue.
Sepsis enhances the anticontractile effect of perivascular adipose tissue (PVAT), which contributes to a reduced response to vasoconstrictor agents. In the early stages of sepsis, the renin-angiotensin-aldosterone system (RAAS) is activated, and this response can lead to poorer clinical outcomes. We hypothesized that AT1 receptors (AT1R) contribute to vascular hyporesponsiveness during sepsis by increasing the expression of inducible nitric oxide synthase (iNOS) in the periaortic PVAT, resulting in elevated nitric oxide (NO) production. In our study, male Wistar Hannover rats underwent lethal sepsis via a cecal ligation and puncture (CLP) model. We evaluated the role of AT1R in sepsis-induced PVAT dysfunction by administering a single dose of losartan (a selective AT1R antagonist; 10 mg/kg, gavage) to the rats 1 h prior to the CLP surgery. We observed increased levels of circulating angiotensin II in septic rats. Functional analyses revealed that AT1R blockade prevented the enhanced anticontractile effect of PVAT and the resulting vascular hyporesponsiveness to phenylephrine during sepsis. Additionally, losartan inhibited sepsis-induced iNOS expression and the overproduction of NO in both the PVAT and the aorta. Experiments using 1400W, a selective iNOS inhibitor, indicated that iNOS plays a crucial role in the sepsis-induced increase in the anticontractile effect of PVAT. In summary, AT1R mediate iNOS expression in PVAT, leading to the overproduction of NO, which ultimately contributes to sepsis-induced vasoplegia. Furthermore, AT1R-mediated iNOS expression is an important mechanism related to vasoplegia in the vasculature. The present results implicate AT1R as active players in sepsis-induced PVAT and vascular dysfunction.
期刊介绍:
Pflügers Archiv European Journal of Physiology publishes those results of original research that are seen as advancing the physiological sciences, especially those providing mechanistic insights into physiological functions at the molecular and cellular level, and clearly conveying a physiological message. Submissions are encouraged that deal with the evaluation of molecular and cellular mechanisms of disease, ideally resulting in translational research. Purely descriptive papers covering applied physiology or clinical papers will be excluded. Papers on methodological topics will be considered if they contribute to the development of novel tools for further investigation of (patho)physiological mechanisms.